Additional Information
Market: ASX
Sector: Energy
EPIC: EXR
Latest Price: A$0.06  (7.41% Ascending)
52-week High: A$0.09
52-week Low: A$0.03
Market Cap: A$16.08M
1 year chart
1 day chart
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Elixir Petroleum
www.elixirpetroleum.com

Elixir Petroleum is an international exploration and production company listed on the Australian Stock Exchange (ASX:EXR). Elixir holds interests in producing gas and condensate fields located in the Gulf of Mexico and has extensive interests in exploration and appraisal licences in the UK North Sea. Elixir has recently acquired interests in two producing fields in the Gulf of Mexico which provide the group with cashflow from sales of gas and condensate. The company is focused on increasing its presence on the shallow water shelf of the Gulf of Mexico and continues to examine new projects in which to participate. Such projects typically display discovered reserves, nearby infrastructure and short cycle times to first production and cashflow.

Pdf

Elixir Petroleum soaring share price prompts ASX 'please explain'

6th Jan 2011, 6:03 am

Junior resource stocks are sparking massive interest in the first few trading days of 2011, with Elixir Petroleum (ASX: EXR) shares spiking to $0.135 in intra-day trading today, up 57% from $0.086 on Friday 31 December, prompting an ASX price query.

Elixir responded to the ASX stating it is not aware of any material information that has not been released to the market which may have sparked the sudden investor interest in the stock.

In November 2010 Elixir was offered a new North Sea licence, provisionally being awarded the Southern part of Block 30/25.

Block 30/25 is located in the Eastern margin of the central UK North Sea, and is adjacent to the now abandoned Ardmore field, which was the first offshore oil production in the UK producing almost 80 million barrels of oil.

Block 30/25 was offered by way of a promote licence to Elixir as operator and 100% interest holder.

Elixir shares have subsequently eased slightly in afternoon trade, last changing hands at $0.125.

 

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.